# Effect of Insulin Sensitizer Therapy on Atherothrombotic and Inflammatory Profiles Associated With Insulin Resistance

> **NCT00443755** · PHASE2 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 28 (actual)

## Conditions studied

- Type 2 Diabetes
- Insulin Resistance
- Metabolic Syndrome

## Interventions

- **DRUG:** metformin
- **DRUG:** pioglitazone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00443755
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2013-10-31

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00443755

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00443755, "Effect of Insulin Sensitizer Therapy on Atherothrombotic and Inflammatory Profiles Associated With Insulin Resistance". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00443755. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*